Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial
Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial have?
Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial has 149 citations in the OpenAlex counts ScholarIQ stores.
When was Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial published?
Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial has 2015 year in the ScholarIQ index.
What is the open-access status of Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial?
Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial has hybrid oa status in the ScholarIQ index.
What is the DOI of Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial?
The DOI for Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial is on the source record.
What is the PMID of Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial?
The PMID for Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial is on the source record.
What is the OpenAlex record for Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial?
The OpenAlex for Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial is on the source record.